RxDoctor Payments Data

Tara Messer, NP

Nurse Practitioner · Rome, GANPI 1699191130

Payments from drug & device makers

$1,039in general payments, 2019–2025

Across 52 payments — averaging $19.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$160
  • Pfizer$144
  • Astellas Pharma US Inc$127
  • Urovant Sciences Inc$99
  • ABC Home Medical Supply, Inc.$80
  • Myriad Genetic Laboratories, Inc.$66
  • plus $362 from 14 others

What the payments were for

  • Food & beverage$95292%
  • Education$878%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,039 in reported general payments places this provider in the 75th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$41,098
Medicare patients
311
Services billed
1,371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron267$194,661
MyrbetriqMirabegron205$136,453
Solifenacin Succinate138$6,118
Fesoterodine Fumarate ErFesoterodine Fumarate29$3,447
Trospium Chloride23$1,296
Tolterodine Tartrate ErTolterodine Tartrate28$1,263
Estradiol16$1,071
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst81$952
CefuroximeCefuroxime Axetil64$866
Tamsulosin Hcl44$712
Trimethoprim33$483
Oxybutynin Chloride ErOxybutynin Chloride34$391
Oxybutynin Chloride13$299
NitrofurantoinNitrofurantoin Macrocrystal36$297
Cephalexin82$249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$160$194,661267 claims
Astellas Pharma US IncMyrbetriq$127$136,453205 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Rome

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →